Heron Therapeutics, Inc.

Heron Therapeutics, Inc. company information, Employees & Contact Information

Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.

Company Details

Employees
187
Founded
-
Address
4242 Campus Point Court,
Phone
800-962-4284
Email
in****@****ntx.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
San Diego, CA
Looking for a particular Heron Therapeutics, Inc. employee's phone or email?

Heron Therapeutics, Inc. Questions

News

Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 - Sahm

Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 Sahm

Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile - Yahoo Finance

Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile Yahoo Finance

Heron Therapeutics (NASDAQ: HRTX) to report third‑quarter results Nov. 4 at 8:30 a.m. ET - Stock Titan

Heron Therapeutics (NASDAQ: HRTX) to report third‑quarter results Nov. 4 at 8:30 a.m. ET Stock Titan

Biotech Leader Heron Therapeutics Sets Q2 Earnings Call: Key Financial Results Coming August 11 - Stock Titan

Biotech Leader Heron Therapeutics Sets Q2 Earnings Call: Key Financial Results Coming August 11 Stock Titan

Cinvanti Single-Dose Regimen Approved for Patients Receiving Moderately Emetogenic Chemotherapy - Medical Professionals Reference

Cinvanti Single-Dose Regimen Approved for Patients Receiving Moderately Emetogenic Chemotherapy Medical Professionals Reference

Heron Therapeutics Accelerates Q2 2025 Earnings Release: New Date and Key Details Revealed - Stock Titan

Heron Therapeutics Accelerates Q2 2025 Earnings Release: New Date and Key Details Revealed Stock Titan

Top Heron Therapeutics, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant